Cite

HARVARD Citation

    Simonini, G. et al. (n.d.). AB1147 Treatment of blau syndrome-related uveitis with the long-acting IL-1 inhibitor CANAKINUMAB: 6 months follow-up. Annals of the rheumatic diseases. p. 703. [Online]. 
  
Back to record